Medication info
Tramaset Tablet

Tramaset Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
Light yellow oblong film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200804557 · Notified 2008.04.23 · Insurance code 644102010

Summary

Main use
Relief of moderate~severe acute·chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term use is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should be continued. Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years and older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term use is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should be continued.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Relief of moderate~severe acute·chronic pain

  • Moderate acute pain
  • moderate chronic pain
View approved original text

This medication is used for the relief of acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term use is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should be continued. Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years and older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term use is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should be continued.

Precautions

This drug can burden the liver, so individuals who regularly consume more than three glasses of alcohol daily must consult their doctor or pharmacist before use. If a rash or adverse reaction occurs during treatment, discontinue use immediately and seek medical attention. Exceeding the recommended dosage can increase the risk of seizures, and this risk may be further heightened when combined with certain antidepressants or narcotic analgesics. Patients with severe respiratory disease must take this medication in a monitored environment due to the risk of respiratory depression. Using this drug with alcohol or central nervous system depressants can cause severe drowsiness, respiratory depression, or coma, so this combination should be avoided. Patients with head injuries or brain diseases need to be cautious, as this medication may exacerbate symptoms due to respiratory depression. This medication contains narcotic analgesic components, which can lead to physical and psychological dependence; thus, consideration of dependency risk is necessary for long-term use. Patients with poor liver function must consult a doctor before use due to the potential for liver damage caused by the acetaminophen component in this medication. Patients with certain genetic metabolic traits may excessively accumulate the active ingredient, leading to severe respiratory depression, so careful monitoring is necessary. This medication should not be administered to children and adolescents, especially those under 12 years old or those under 18 years old who have undergone tonsillectomy or adenoidectomy. This medication can exacerbate sleep apnea or hypoxemia, so patients with these symptoms should regularly evaluate their condition and adjust the dosage as needed. Drowsiness or dizziness may occur while taking this medication, requiring special caution when driving or operating machinery. Overdosing on this medication can result in severe respiratory depression, seizures, or liver damage; therefore, maintaining strict adherence to dosage is crucial, and emergency treatment should be sought immediately in case of overdose. During treatment, special care must be taken to avoid co-use with other tramadol formulations or medications containing acetaminophen and to follow the doctor's instructions regarding drug interactions.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, fatal respiratory suppression, hyponatremia, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hyperreactivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disorders, confusion, spatial disorientation, excitement, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory loss, tremor, paresthesia, attention deficit disorder, syncope, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, weakness, chest pain, emotional abnormality, chills, chest discomfort, lethargy, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reaction, unstable emotions, delirium, suicidal ideation, muscle rigidity syndrome, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disorders, prolonged prothrombin time, thrombocytopenia, agranulocytosis, hematological disorders, hypoprothrombinemia, high anion gap metabolic acidosis, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, exacerbation of migraine, involuntary muscle contractions, exercise-induced dyspnea, cough, bronchitis, urinary retention, frequency of urination, kidney function abnormalities, oliguria, rash, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, increased white blood cells, leukocytosis, cardiovascular arrhythmias, exacerbation of hypertension, aortic stenosis, hemorrhage, increased cholesterol, tinnitus, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, upper respiratory tract syndrome, oral thrush, excitement, hyperactivity, panic attack, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system response, urticaria, bronchospasm, toxic skin necrosis, allergic reaction, withdrawal symptoms, severe anxiety, hypoglycemia, hypotension, extreme fatigue, decreased appetite, weight loss, severe abdominal pain, opiate-induced hyperalgesia, withdrawal syndrome, respiratory arrest, heart attack, QT prolongation, hypersomnia, coma, seizures, death

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent exposure to air or moisture, and keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness.

Appearance and packaging

Appearance

Light yellow oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.